...
首页> 外文期刊>Archives of medical research >Comparative Assessment of Serum Adipokines Zinc-α2-glycoprotein and Adipose Triglyceride Lipase, and Cardiovascular Risk Factors Between Normal Weight and Obese Patients with Hemodialysis
【24h】

Comparative Assessment of Serum Adipokines Zinc-α2-glycoprotein and Adipose Triglyceride Lipase, and Cardiovascular Risk Factors Between Normal Weight and Obese Patients with Hemodialysis

机译:血清己芯锌-α2-糖蛋白和脂肪甘油三酯脂肪酶对比较评估,以及血液透析患者正常重量与肥胖患者的心血管危险因素

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Background Little is known about the potential relationship of obesity, adipose tissue and novel adipokines with cardiometabolic risk factors in end-stage renal disease. Zinc-α2-glycoprotein (ZAG) and adipose triglyceride lipase (ATGL) are novel adipokines with proposed desirable effects on inflammation, and lipid and glucose metabolism. The aim of this study was to investigate serum concentrations of ZAG and ATGL, and the relationship of these adipokines with cardiovascular risk factors in normal weight (NW) and obese (OB) patients undergoing hemodialysis. Methods Patients with regular hemodialysis including 44 normal weight (18.5 2 ) and 44 obese (BMI≥30?kg/m 2 ) were enrolled. Serum lipid profile, high-sensitivity C-reactive protein (hsCRP) and nitric oxide metabolites along with ZAG and ATGL concentrations were assessed. Results ZAG concentrations were significantly lower in OB compared to NW group (100?±?34 vs. 106?±?31?ng/ml; p ?=?0.007). No significant difference was observed in ATGL between the two groups. A significant inverse correlation between ZAG and HDL ( r ?=??0.236, p ?=?0.048) and a marginal inverse correlation between ATGL and HDL ( r ?=??0.211, p ?=?0.078) were observed in all patients. ZAG had positive correlations with triglyceride/HDL ( r ?=?0.279, p ?=?0.019), cholesterol/HDL ( r ?=?0.319, p ?=?0.007), and LDL/HDL ( r ?=?0.26, p ?=?0.029) ratios. Among cardiovascular risk factors, only LDL/HDL ratio and hsCRP were significantly higher in OB patients ( p ?=?0.009 and p ?=?0.038, respectively). Conclusions Serum concentrations of ZAG, but not ATGL, were significantly lower in the OB group. It appears that obesity overrides the role of hemodialysis in determining ZAG concentration. In contrast, uremic condition might overshadow the role of obesity in determining levels of traditional cardiovascular risk factors.
机译:背景技术对于肥胖,脂肪组织和新型脂肪因子具有终末期肾病中的心细素危险因素的潜在关系。锌-α2-糖蛋白(ZAG)和脂肪甘油三酯脂肪酶(ATGL)是新的脂肪因子,具有提出对炎症的理想效果,以及脂质和葡萄糖代谢。本研究的目的是研究血清浓度的ZAG和ATGL,以及这些adipokines在正常重量(NW)和肥胖(OB)血液透析患者中​​的心血管危险因素的关系。方法常规血液透析患者均注册了44例正常重量(18.52)和44肥胖(BMI≥30kg / m 2)。评估血清脂质谱,高敏感性C-反应性蛋白(HSCRP)和一氧化氮代谢物以及ZAG和ATGL浓度。结果与NW组相比,ZAG浓度显着降低(100?±34对106?±31.αn_mg/ ml; p?= 0.007)。在两组之间的ATGL中没有观察到显着差异。在所有患者中观察到ZAG和HDL之间的显着逆相关(r?= 0.236,p≤0.048)和ATGL和HDL之间的边际逆相关性(r?= = 0.211,p?= 0.078) 。 ZAG与甘油三酯/ HDL有正相关(R?= 0.279,P?= 0.019),胆固醇/ HDL(R?= 0.319,P?= 0.007)和LDL / HDL(R?= 0.26, P?= 0.029)比率。在心血管危险因素中,OB患者只有LDL / HDL比率和HSCRP显着较高(P?= 0.009和P?= 0.038)。结论OB组中血清血清浓度,但不是ATGL,显着较低。似乎肥胖似乎会覆盖血液透析在确定ZAG浓度方面的作用。相比之下,尿毒症状况可能会在确定传统心血管危险因素的确定水平时掩盖肥胖的作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号